Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
05/24/1995 | CN1102757A Colloidally dispersible acive compound |
05/24/1995 | CN1028542C Anticancer antibiotic MZ43-37F11 substance, the production and uses thereof |
05/24/1995 | CN1028531C 2-oxa-1-oxo-8-azaspiro ¾4,5 decane derivatives, pharmaceutical compositions containing them and process for preparing same |
05/24/1995 | CN1028529C Interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in treatment of thrombotic and vasospastic disease |
05/24/1995 | CN1028528C Salts of optically active 4-hydroxy-8-(3-lower alkoxy-4-phenylsulfinylphenyl) pyrazolo |1,5-a¨-1,3,5-triazines |
05/24/1995 | CN1028527C Process for preparing of coumarin derivatives |
05/24/1995 | CN1028521C Therapeutic agents |
05/24/1995 | CA2136295A1 Pharmaceutical agents for the inhibition of angiogenesis |
05/24/1995 | CA2136288A1 Imidazopyridazines |
05/23/1995 | US5418255 Method of treating alcohol dependence |
05/23/1995 | US5418252 Method for inhibiting cartilage degradation |
05/23/1995 | US5418251 Topical composition for accelerating wound healing |
05/23/1995 | US5418249 Renin inhibitors |
05/23/1995 | US5418248 2-thienylimidazo[2,1-β]benzothiazole-3-acetic acid derivatives, their preparation and their use |
05/23/1995 | US5418245 For inhibiting cell proliferation |
05/23/1995 | US5418243 Anticholesterol agents |
05/23/1995 | US5418241 Antiserotonin agents |
05/23/1995 | US5418239 Acylcoenzyme a:cholesterol acyltransferase inhibitors |
05/23/1995 | US5418238 17β-substituted 4-aza-5α-androstan-3-one derivatives |
05/23/1995 | US5418237 Indole derivatives |
05/23/1995 | US5418235 Hypotensive, Parkinson's disease, schizophrenia |
05/23/1995 | US5418234 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
05/23/1995 | US5418233 For inhibiting cell aggregation |
05/23/1995 | US5418232 Hypotensive, increases renal blood flow |
05/23/1995 | US5418228 Contraceptive regimen |
05/23/1995 | US5418227 For treatment of estrogen deficiency symptoms |
05/23/1995 | US5418226 Neuromuscular blocking agent anesthetic, fast-acting |
05/23/1995 | US5418224 Antibiotic |
05/23/1995 | US5418223 Method for lyophilization of cyclophosphamide and product |
05/23/1995 | US5418220 Method for treating constipation using dimethicone |
05/23/1995 | US5418219 Pharmaceutical composition for treatment of adult respiratory distress syndrome containing human ANP |
05/23/1995 | US5418218 Controlling food intake |
05/23/1995 | US5418152 Acidic polycyclic ether antibiotic |
05/23/1995 | US5417980 Pharmaceutical compositions and methods for treating the symptoms of overindulgence |
05/23/1995 | US5417978 Liposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and use |
05/23/1995 | CA2048613C Lipid absorption inhibitory composition |
05/23/1995 | CA1335686C Vinblastin and pharmaceutical composition comprising them |
05/23/1995 | CA1335672C Thioformamide derivatives |
05/23/1995 | CA1335655C Vaccines and diagnostic assays for haemophilus influenzae |
05/23/1995 | CA1335651C Method for the treatment or prevention of intrinsically aged skin with retinoids |
05/20/1995 | CA2135597A1 Glutaminase inhibitor |
05/19/1995 | CA2134149A1 Compounds containing a fused multiple ring lactam |
05/19/1995 | CA2118443A1 Aromatase-inhibiting composition containing azole derivative |
05/19/1995 | CA2103399A1 Material for passage through the blood-brain barrier |
05/18/1995 | WO1995013380A2 Method and reagent for treatment of arthritic conditions |
05/18/1995 | WO1995013365A1 Generation of high titers of recombinant aav vectors |
05/18/1995 | WO1995013287A1 New steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances |
05/18/1995 | WO1995013279A1 N-substituted azabicycloalkane derivatives, their preparation and use |
05/18/1995 | WO1995013278A1 Urea derivatives |
05/18/1995 | WO1995013277A1 6-oxo-nucleosides useful as immunosuppressants |
05/18/1995 | WO1995013274A1 Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives |
05/18/1995 | WO1995013272A1 Chroman derivative and medicinal use thereof |
05/18/1995 | WO1995013271A1 Novel taxoids, their preparation and pharmaceutical compositions containing them |
05/18/1995 | WO1995013267A1 Pyrimidine-thioalkyl and alkylether compounds |
05/18/1995 | WO1995013262A1 Substituted phenyl compounds |
05/18/1995 | WO1995013087A1 Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion |
05/18/1995 | WO1995013082A1 Immunotherapy composition and method |
05/18/1995 | WO1995013079A1 Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide |
05/18/1995 | WO1995013078A1 Pharmaceutical composition and use thereof |
05/18/1995 | WO1995013077A1 7β-SUBSTITUTED-4-AZA-5α-CHOLESTAN-3-ONES AS SELECTIVE 5α-REDUCTASE 1 INHIBITORS |
05/18/1995 | WO1995013076A1 Use of steroids with a phenolic a-ring structure for prophylaxis and therapy of radical-mediated cell damage |
05/18/1995 | WO1995013075A1 Method for preventing tissue injury from hypoxia |
05/18/1995 | WO1995013074A1 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection |
05/18/1995 | WO1995013073A1 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections |
05/18/1995 | WO1995013072A1 The use of alfuzosin or terazosin in the treatment of premature ejaculation |
05/18/1995 | WO1995013071A2 Treatment of immunoregulatory disorders |
05/18/1995 | WO1995013070A1 Nedocromil sodium for the treatment of upper respiratory tract infections |
05/18/1995 | WO1995013068A1 Medicinal composition for circulatory organ |
05/18/1995 | WO1995013067A1 Oxazoles for treating cytokine mediated diseases |
05/18/1995 | WO1995013066A1 Pharmaceutical emulsion |
05/18/1995 | WO1995013065A1 Fenbendazole formulations |
05/18/1995 | WO1995013064A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists |
05/18/1995 | WO1995013063A1 HMG-CoA REDUCTASE INHIBITORS IN THE NORMALIZATION OF VASCULAR ENDOTHELIAL DYSFUNCTION |
05/18/1995 | WO1995013062A1 Butyric ester cyto-differentiating agents |
05/18/1995 | WO1995013061A1 Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation |
05/18/1995 | WO1995013060A1 L-arginine and analogues as thrombocyte aggregation inhibitors |
05/18/1995 | WO1995013059A1 Farnesyl derivatives and pharmaceutical compositions containing them |
05/18/1995 | WO1995013058A1 Halogenated mevalonate compositions and uses thereof in ras-dependent cell growth |
05/18/1995 | WO1995013057A1 Antimicrobial method and cosmetic composition |
05/18/1995 | WO1995013055A1 Sustained release formulations for 24 hour release of metoprolol |
05/18/1995 | WO1995013054A1 Process for preparing a clodronate preparation |
05/18/1995 | WO1995013053A1 Taxol formulation |
05/18/1995 | WO1995013048A1 Desquamation compositions containing salicylic acid and zwitterionic compounds |
05/18/1995 | WO1995013046A1 Antiperspirants and method of applying antiperspirant using a shaped article |
05/18/1995 | WO1995012991A1 New beverage |
05/18/1995 | WO1995011682A3 Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents |
05/18/1995 | DE4339198A1 Fungal and bacterial control, esp. of conifer rot in forestry |
05/18/1995 | DE4338948A1 Treating erectile dysfunction without causing side-effects |
05/18/1995 | CA2176386A1 Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide |
05/18/1995 | CA2176368A1 New steroids with radicophilic substituents, a process for manufacturing these, and medications that contain these compounds |
05/18/1995 | CA2176363A1 Substituted phenyl compounds |
05/18/1995 | CA2176134A1 New beverage |
05/18/1995 | CA2176124A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists |
05/18/1995 | CA2176013A1 Treatment of immunoregulatory disorders |
05/18/1995 | CA2175994A1 Process for preparing a clodronate preparation |
05/18/1995 | CA2175897A1 6-oxo-nucleosides useful as immunosuppressants |
05/18/1995 | CA2175824A1 Method and reagent for treatment of arthritic conditions |
05/18/1995 | CA2175683A1 N-substituted azabicycloalkane derivatives, their preparation and use |
05/18/1995 | CA2175564A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease |
05/18/1995 | CA2175384A1 Novel taxoids, their preparation and pharmaceutical compositions containing them |